Characterization of a clinical Clostridioides difficile isolate with markedly reduced fidaxomicin susceptibility and a V1143D mutation in rpoB

ISSN
0305-7453
Date Issued
2019
Author(s)
Riedel, Thomas
Laukien, Friederike
Schober, Isabel
Overmann, Jörg
DOI
10.1093/jac/dky375
Abstract
The identification and characterization of clinical Clostridioides difficile isolates with reduced fidaxomicin susceptibility.